Business Wire

SIGFOX

1.7.2020 10:48:12 CEST | Business Wire | Press release

Share
Condat Introduces IoT on Tunnel Boring Sites Thanks to delaware and Sigfox

Condat, a global specialist in surface chemistry including industrial lubricants, today announced its partnership with Sigfox, the world's leading IoT service provider and initiator of the 0G network. With its long-term partner delaware, an internationally renowned integrator of innovative technology solutions, the two companies have created CondatLink, an IoT solution capable of helping tunnel boring machine operators to better manage their supply and stock of sealant on construction sites.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200701005389/en/

Sealant stock management: a major challenge for tunnel construction

With more than 25 years of experience in the field of tunnels, with more than 4,500 km laid, Condat has unique know-how and an international reputation in its sector. In particular, the company is a leader in the manufacture and supply of tail seal greases, products designed for tunnel construction in wet areas. Tail seal greases are essential for tunnelling especially in the event of water ingress, as job sites risk being delayed and, in the worst case, may even be submerged.

Condat delivers all over the world using 20-ton containers. Until now Condit’s sales teams worked with customers to estimate requirements, without being able to obtain precise information on sealant consumption.

"We needed a solution to prevent our tunnel boring machine customers from running out of sealant on their sites. In the life of a construction site, many parameters can speed up or slow down the consumption of this product. To satisfy our customers, we had to think of a way to find out about it, without having to contact someone on the worksites. We had the feeling that IoT was the right way to go, so we turned to delaware, our technology solutions partner of more than 23 years, to help us," explains Guy Chemisky, Director of Operations at Condat.

CondatLink started as a concept last November at Del20, the delaware working group focused on innovation, where concrete cases and feedback are shared, and in January, the project was launched:

"We started this project together by working on an end-to-end strategy: from the ideas phase to the design of the applications. We then put several people from the IoT ecosystem in touch with each other. Sigfox was chosen to support us during the implementation of this project and the design of the tracking and monitoring equipment," adds Baptiste Duriez, Partner at delaware.

Sigfox was chosen by Condat for its 0G network covering more than 70 countries and regions and its proposal to fully integrate the solution into Condat's SAP environment.

"We were very delighted by the maturity of the thinking. The Condat and delaware teams had carried out an in-depth study of the service experience expected for users and how the solution would fit into production. Even the notion of return on investment with stock management had been analysed. We were therefore able to bring our expertise to the project to introduce a solution very quickly," says Patrick Cason, Managing Director of Sigfox France.

"This project was carried out thanks to a dozen-strong team from Condat, delaware and Sigfox. By combining all these skills, the spirit of innovating together and the desire to co-develop with our suppliers, we managed to finalize this project in a very short timeframe and in the middle of a period of lockdown," adds Guy Chemisky.

The IoT for better consumption monitoring on construction sites

Sigfox's expertise has led to the implementation of the CondatLink solution, which will be available internationally and will enable more precise information about the level of consumption of sealant on building sites, thanks to a connected device that monitors the opening and closing of sealant drums.

The device is attached to the drums as soon as they leave the production plant. It is small (116x45x30mm), light (around 100g) and has, at least, a one-year battery life. As for the software, it uses Sigfox Monarch (international device, frequency management) and Atlas (geolocation) technologies. It will emit a message regularly to signal the location of the drum (asset tracking) while emitting regular messages indicating its change of state when the drum is opened (asset monitoring).

The information obtained by this connected device is sent to Condat and their clients via the Sigfox 0G network and available on a dedicated tracking application. This platform will take the form of a dashboard allowing the customer to track consumption and stock, and Condat to manage its deliveries worldwide.

Aware of environmental issues, Condat has been offering solutions for more than 20 years that are more respectful of individuals and the planet. The development of CondatLink is part of this approach. Thus, with delaware and Sigfox, Condat wanted to pay particular attention to the ecodesign and optimization of the battery. Moreover, the optimisation of transport and the better planning of deliveries, obtained via this solution, enable the company to avoid air transport as much as possible and, therefore, to greatly reduce carbon footprint.

A first use case that aims to deploy tens of thousands of connected objects

A test phase is planned for July with the implementation of this solution over two sites. Initially, the challenge will be the deployment of tens of thousands of objects by next year.

"Tomorrow, we will be able to go further than just monitoring the consumption of sealant on building sites. It will be possible to do this with many other products and for sectors other than tunnel builders. One of our major technological challenges in the coming years will be to make greater use of the data we have been collecting for more than 20 years to build predictive models and serve our customers better ," concludes Guy Chemisky.

About Sigfox

Sigfox is the initiator of the 0G network and the world’s leading IoT (Internet of Things) service provider. Its global network allows billions of devices to connect to the Internet, in a straightforward way, while consuming as little energy as possible. Sigfox’s unique approach to device-to-cloud communications addresses the three greatest barriers to global IoT adoption: cost, energy consumption and global scalability.

Today, the network is available in 70+ countries, with 1 billion people covered. ISO 9001 certified and surrounded by a large ecosystem of partners and IoT key players, Sigfox empowers companies to move their business model towards more digital services, in key areas such as Asset Tracking and Supply Chain. Founded in 2010 by Ludovic Le Moan and Christophe Fourtet, the company is headquartered in France and has offices in Madrid, Munich, Boston, Dallas, San Jose, Dubai, Singapore, Sao Paulo and Tokyo.

About Condat

Condat, an independent international group of French origin, formulates and manufactures a complete range of lubricants and special chemicals for the world of industry.

With proven technical and sales expertise over 160 years, the CONDAT group offers one of the widest ranges on the market, and knows how to satisfy the requirements of many fields of application: wire drawing, tunnel boring, forging, glass, machining, industrial maintenance...

CONDAT recommends to its customers the best lubrication solution from a technical and economical point of view, while taking into account environmental and safety issues.

Leader in tunnelling:

Since 1989, Condat has been developing a complete range of products, lubricants and additives meeting the technical, safety and environmental requirements of underground works such as : tails seal greases, main bearing tail seal greases, hydraulic fluids, foaming agents and polymers, additives for ground treatment... CONDAT, worldwide leader on this application, offers a complete range of biodegradable and fire resistant products dedicated to this market. With the support of a dedicated team of experts and complete services (training, advice...), CONDAT does its utmost to support tunnel specialists whatever the type of tunnel boring machine and the constraints of the construction site.

About delaware

delaware is a global company that delivers advanced ICT solutions and services, recognized on the French market and internationally, delaware helps companies in the daily use of their information system, thanks to its 350 experts based in Lyon, Lille, Nantes, Paris, and Bordeaux. delaware is an internationally renowned company, present in 12 countries with 24 offices.

delaware guides its clients throughout the transformation of their business by relying on its local agencies and deploying the solutions of its main business partners SAP & Microsoft.

Business transformation, next-gen applications, customer connection, data and analysis, applied innovations, information management, maintenance, training: delaware supports its customers in their digital transformation thanks to the most innovative technologies (next-gen erp, artificial intelligence, blockchain, cloud, intelligent applications, IoT, virtual and augmented reality, chatbot, etc.), particularly in the retail, food and beverage, automotive, engineering and professional services industries.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release

For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will

Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release

Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye